Percutaneous Renal Cryoablation: Local Control at Mean 26 Months of Followup-Reference-Cited by-同舟云学术

Percutaneous Renal Cryoablation: Local Control at Mean 26 Months of Followup

Published:2010-10 Issue:4 Volume:184 Page:1291-1295
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Atwell Thomas D.¹,Callstrom Matthew R.¹,Farrell Michael A.¹,Schmit Grant D.¹,Woodrum David A.¹,Leibovich Bradley C.¹,Chow George K.¹,Patterson David E.¹,Blute Michael L.¹,Charboneau J. William¹

Affiliation:

1. Departments of Radiology (TDA, MRC, GDS, DAW, JWC) and Urology (BCL, GKC, DEP, MLB), Mayo Clinic, Rochester, Minnesota

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference27 articles.

1. Rising incidence of renal cell cancer in the United States;Chow;JAMA,1999

2. Rising incidence of small renal masses: a need to reassess treatment effect;Hollingsworth;J Natl Cancer Inst,2006

3. Incidental renal cell carcinoma–age and stage characterization and clinical implications: study of 1092 patients (1982–1997);Luciani;Urology,2000

4. Pathological features of renal neoplasms classified by size and symptomatology;Schlomer;J Urol,2006

5. Renal cell cancer stage migration: analysis of the National Cancer Data Base;Kane;Cancer,2008

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospital-Level Variability in the Adoption of Image-Guided Focal Therapy for Localized Prostate and Kidney Cancer;Clinical Genitourinary Cancer;2024-12

2. Intraoperative Cryotherapy in the Treatment of Metastatic Renal Cell Carcinoma of the Bone;Orthopedics;2021-09

3. Long-term renal function outcomes after renal cryoablation complicated by major hemorrhage requiring selective transarterial embolization;Abdominal Radiology;2021-06-24

4. Percutaneous cryoablation vs. open partial nephrectomy in small kidney cancers: the Italian experience;Minerva Urology and Nephrology;2021-05

5. Percutaneous cryoablation vs. open partial nephrectomy in small kidney cancers: the Italian experience;MINERVA UROL NEPHROL;2021